Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2008 2
2009 2
2010 2
2011 3
2012 4
2013 4
2014 5
2015 5
2016 2
2017 5
2018 3
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Results by year
Filters applied: . Clear all
Page 1
A higher throughput and physiologically relevant two-compartmental human ex vivo intestinal tissue system for studying gastrointestinal processes.
Stevens LJ, van Lipzig MMH, Erpelinck SLA, Pronk A, van Gorp J, Wortelboer HM, van de Steeg E. Stevens LJ, et al. Among authors: van de steeg e. Eur J Pharm Sci. 2019 Sep 1;137:104989. doi: 10.1016/j.ejps.2019.104989. Epub 2019 Jul 10. Eur J Pharm Sci. 2019. PMID: 31301485
Proteomics of human liver membrane transporters: a focus on fetuses and newborn infants.
van Groen BD, van de Steeg E, Mooij MG, van Lipzig MMH, de Koning BAE, Verdijk RM, Wortelboer HM, Gaedigk R, Bi C, Leeder JS, van Schaik RHN, van Rosmalen J, Tibboel D, Vaes WH, de Wildt SN. van Groen BD, et al. Among authors: van de steeg e. Eur J Pharm Sci. 2018 Nov 1;124:217-227. doi: 10.1016/j.ejps.2018.08.042. Epub 2018 Aug 30. Eur J Pharm Sci. 2018. PMID: 30171984 Free article.
Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
Notenboom S, Weigand KM, Proost JH, van Lipzig MMH, van de Steeg E, van den Broek PHH, Greupink R, Russel FGM, Groothuis GMM. Notenboom S, et al. Among authors: van de steeg e. Eur J Pharm Sci. 2018 Mar 30;115:175-184. doi: 10.1016/j.ejps.2018.01.007. Epub 2018 Jan 5. Eur J Pharm Sci. 2018. PMID: 29309877 Free article.
Corrigendum to 'Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs' [European Journal of Pharmaceutical Sciences 115 (2018) 175-184].
Notenboom S, Weigand KM, Proost JH, van Lipzig MM, van de Steeg E, van den Broek PHH, Greupink R, Russel FGM, Groothuis GMM. Notenboom S, et al. Among authors: van de steeg e. Eur J Pharm Sci. 2018 May 30;117:392-393. doi: 10.1016/j.ejps.2018.04.005. Eur J Pharm Sci. 2018. PMID: 29650218 No abstract available.
Variability in Mass Spectrometry-based Quantification of Clinically Relevant Drug Transporters and Drug Metabolizing Enzymes.
Wegler C, Gaugaz FZ, Andersson TB, Wiśniewski JR, Busch D, Gröer C, Oswald S, Norén A, Weiss F, Hammer HS, Joos TO, Poetz O, Achour B, Rostami-Hodjegan A, van de Steeg E, Wortelboer HM, Artursson P. Wegler C, et al. Among authors: van de steeg e. Mol Pharm. 2017 Sep 5;14(9):3142-3151. doi: 10.1021/acs.molpharmaceut.7b00364. Epub 2017 Aug 16. Mol Pharm. 2017. PMID: 28767254 Free article.
Functions of OATP1A and 1B transporters in vivo: insights from mouse models.
Iusuf D, van de Steeg E, Schinkel AH. Iusuf D, et al. Among authors: van de steeg e. Trends Pharmacol Sci. 2012 Feb;33(2):100-8. doi: 10.1016/j.tips.2011.10.005. Epub 2011 Nov 28. Trends Pharmacol Sci. 2012. PMID: 22130008 Review.
Comparison of In Vitro Assays in Selecting Radiotracers for In Vivo P-Glycoprotein PET Imaging.
Raaphorst RM, Savolainen H, Cantore M, van de Steeg E, van Waarde A, Colabufo NA, Elsinga PH, Lammertsma AA, Windhorst AD, Luurtsema G. Raaphorst RM, et al. Among authors: van de steeg e. Pharmaceuticals (Basel). 2017 Sep 20;10(3):76. doi: 10.3390/ph10030076. Pharmaceuticals (Basel). 2017. PMID: 29036881 Free PMC article.
Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group.
Brouwer KL, Aleksunes LM, Brandys B, Giacoia GP, Knipp G, Lukacova V, Meibohm B, Nigam SK, Rieder M, de Wildt SN; Pediatric Transporter Working Group. Brouwer KL, et al. Clin Pharmacol Ther. 2015 Sep;98(3):266-87. doi: 10.1002/cpt.176. Clin Pharmacol Ther. 2015. PMID: 26088472 Free PMC article. Review.
The consequence of regional gradients of P-gp and CYP3A4 for drug-drug interactions by P-gp inhibitors and the P-gp/CYP3A4 interplay in the human intestine ex vivo.
Li M, de Graaf IA, van de Steeg E, de Jager MH, Groothuis GM. Li M, et al. Among authors: van de steeg e. Toxicol In Vitro. 2017 Apr;40:26-33. doi: 10.1016/j.tiv.2016.12.002. Epub 2016 Dec 7. Toxicol In Vitro. 2017. PMID: 27939799
Down-regulation of OATP1B proteins correlates with hyperbilirubinemia in advanced cholestasis.
Sticova E, Lodererova A, van de Steeg E, Frankova S, Kollar M, Lanska V, Kotalova R, Dedic T, Schinkel AH, Jirsa M. Sticova E, et al. Among authors: van de steeg e. Int J Clin Exp Pathol. 2015 May 1;8(5):5252-62. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26191226 Free PMC article.
32 results
Jump to page
Feedback